Fig 1.
Patient disposition in the multicenter, open-label, randomized controlled trial (a) and the retrospective study (b) of hydroxychloroquine. Abbreviations: HCQ: hydroxychloroquine; SOC: standard of care.
Table 1.
Baseline demographic and clinical characteristics of participants in the multi-center, open-label, randomized clinical trial and the retrospective observational study.
Fig 2.
Probabilities of non-negative responses vs. time (days) for subjects in the HCQ and SOC groups in the multicenter, open-label, randomized controlled trial.
Abbreviations: HCQ: hydroxychloroquine; SOC: standard of care.
Fig 3.
Mean Ct value of viral rRT-PCR vs. time (days) for subjects in the HCQ and SOC groups in the multicenter, open-label, randomized controlled trial.
Abbreviations: Ct: Cycle threshold; HCQ: hydroxychloroquine; rRT-PCR: real-time reverse transcription polymerase chain reaction; SOC: standard of care.
Table 2.
Proportions of negative rRT-PCR assessments on day 14 and median times to negative rRT-PCR results after randomization in the multicenter, open-label, randomized controlled trial.
Table 3.
Comparison of area under curve of Ct value between subjects in the HCQ and SOC groups in the multicenter, open-label, randomized controlled trial.